Hetero Labs Limited Atazanavir Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Atazanavir Export Records India — #3 Exporter, 43 Shipments, $2.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atazanavir

India Pharmaceutical Trade Intelligence

$71.2M17 Suppliers88 CountriesHS 30049099

ExportsIndia → RWANDA23.2%India → TANZANIA11.2%

ImportsUNITED STATES → India$134.1K SINGAPORE → India$5.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: DIGECITSS -MINISTERIO

Hetero Labs Limited — Atazanavir Exporter #3 | $2.1M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Atazanavir Exporter Profile

Indian Pharmaceutical Exporter · #3 for Atazanavir · $2.1M export value · DGFT Verified

Hetero Labs Limited is the #3 Indian exporter of Atazanavir with $2.1M in export value and 43 verified shipments. Hetero Labs Limited holds a 3.0% market share in Atazanavir exports across 5 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Atazanavir Export Profile: Buyers & Destinations

Hetero Labs Limited Atazanavir export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Atazanavir?

Country	Value	Shipments	Share
COLOMBIA	$1.2M	25	64.4%
UNITED STATES	$597.3K	14	31.9%
TRINIDAD AND TOBAGO	$46.3K	1	2.5%
CHILE	$21.2K	1	1.1%
RUSSIA	$191	2

Who Are the Top Buyers of Atazanavir from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	COLOMBIA	$1.0M	23
TO THE ORDER OF.,	COLOMBIA	$250.0K	5
TO THE ORDER	UNITED STATES	$137.8K	3
TO THE ORDER OF....	UNITED STATES	$104.2K	3
TO THE ORDER OF....................	COLOMBIA	$100.0K	2
TO THE ORDER OF---	COLOMBIA	$50.0K	1
SEVEN PHARMA COLOMBIA SAS	COLOMBIA	$50.0K	1
VERNON TECHNOLOGIES LIMITED	TRINIDAD AND TOBAGO	$46.3K	1
CAMBER PHARMACEUTICALS INC	UNITED STATES	$46.2K	1
CAMBER PHARMACEUTICALS INC.	UNITED STATES	$45.3K	1

Hetero Labs Limited supplies Atazanavir to 11 buyers globally. The largest buyer is TO THE ORDER OF (COLOMBIA), followed by TO THE ORDER OF., (COLOMBIA) and TO THE ORDER (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atazanavir Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
VIRATAZ RITONAVIR 100 MG + ATAZANAVIR SU	$300.0K	6
VIRATAZ (RITONAVIR+ATAZANAVIR SULFATE 100MG+300MG TABLET)NOS	$269.1K	6
ATAZANAVIR SULFATE CAPSULE	$173.5K	4
VIRATAZ RITONAVIR+ATAZANAVIR SULFATE TABLET (19764 X 30's PACK)	$147.0K	3
VIRATAZ (RITONAVIR+ATAZANAVIR SULFATE TABLET)	$139.4K	3
ATAZANAVIR SULFATE CAPSULE	$137.8K	3
(VIRATAZ) RITONAVIR 100 MG + ATAZANAVIR	$100.0K	2
VIRATAZ RITONAVIR+ATAZANAVIR SULFATE TABLET	$100.0K	2
ATAZANAVIR SULFATE 300MG CAPSULE	$64.4K	2
VIRATAZ RITONAVIR 100 MG +ATAZANAVIR SUL	$50.0K	1

Hetero Labs Limited exports 21 distinct Atazanavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VIRATAZ RITONAVIR 100 MG + ATAZANAVIR SU with 6 shipments worth $300.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Hetero Labs Limited Compare to Nearest Atazanavir Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$11.3M	226	55	$50.0K
2	EMCURE PHARMACEUTICALS LIMITED	$8.0M	159	48	$50.0K
3	HETERO LABS LIMITED ★	$2.1M	43	5	$50.0K
4	EMCURE PHARMACEUTICALS LTD	$400.0K	8	6	$50.0K
5	CIPLA LIMITED	$400.0K	8	1	$50.0K

Hetero Labs Limited ranks #3 among 17 Indian Atazanavir exporters. Average shipment value of $50.0K compared to the market average of $1.3M. The closest competitors by value are MYLAN LABORATORIES LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Atazanavir Exports?

Port	Shipments	% Share
SAHAR AIR	163	34.5%
SAHAR AIR CARGO ACC (INBOM4)	133	28.1%
NHAVA SHEVA SEA (INNSA1)	29	6.1%
Bombay Air	25	5.3%
JNPT	15	3.2%
JNPT/ NHAVA SHEVA SEA	15	3.2%
HYDERABAD ACC (INHYD4)	12	2.5%
Bombay Air Cargo	9	1.9%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Atazanavir Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atazanavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 43 individual customs records matching Hetero Labs Limited exporting Atazanavir, covering 21 formulations to 5 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 88+ countries, 199+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atazanavir

Atazanavir

Hetero Labs Limited — Atazanavir Exporter Profile

Hetero Labs Limited — Atazanavir Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Atazanavir?

Who Are the Top Buyers of Atazanavir from Hetero Labs Limited?

What Is India's Total Atazanavir Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Atazanavir Exports?

How Does Hetero Labs Limited Compare to Other Indian Atazanavir Exporters?

What Atazanavir Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Atazanavir to Key Markets

United States — FDA

How Does Hetero Labs Limited Compare to Nearest Atazanavir Exporters?

Which Indian Ports Ship Atazanavir Exports?

What Other Antiviral & HIV Medications Products Does Hetero Labs Limited Export?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Atazanavir Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atazanavir Export Data from Hetero Labs Limited

Atazanavir Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source